These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11352361)

  • 21. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
    Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma tryptophan levels and prolactin response to fenfluramine in healthy volunteers.
    FitzGerald M; Malone K; Li S; Suckow R; Mann JJ
    Biol Psychiatry; 1997 Sep; 42(5):416-8. PubMed ID: 9276083
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    Yamada J; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prolactin response to buspirone in chronic fatigue syndrome.
    Sharpe M; Clements A; Hawton K; Young AH; Sargent P; Cowen PJ
    J Affect Disord; 1996 Nov; 41(1):71-6. PubMed ID: 8938208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.
    Baumann MH; Rothman RB
    Biol Psychiatry; 1998 Oct; 44(7):578-91. PubMed ID: 9787882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.
    Gatch MB
    Life Sci; 2003 Aug; 73(11):1347-67. PubMed ID: 12850497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 5-HT2C/2B receptor agonist m-chlorophenylpiperazine (mCPP) inhibits 2-deoxy-D-glucose (2-DG)-induced hyperphagia in rats.
    Sugimoto Y; Yoshikawa T; Noma T; Yamada J
    Biol Pharm Bull; 2001 Dec; 24(12):1431-3. PubMed ID: 11767117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT2C receptor activation decreases appetite and body weight in obese subjects.
    Sargent PA; Sharpley AL; Williams C; Goodall EM; Cowen PJ
    Psychopharmacology (Berl); 1997 Oct; 133(3):309-12. PubMed ID: 9361339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 1998 Jun; 137(3):292-302. PubMed ID: 9683007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tryptophan in fatigue in different conditions of stress.
    Castell LM; Yamamoto T; Phoenix J; Newsholme EA
    Adv Exp Med Biol; 1999; 467():697-704. PubMed ID: 10721121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrinological responses to 5-HT.
    Cowen PJ; Anderson IM; Gartside SE
    Ann N Y Acad Sci; 1990; 600():250-7; discussion 257-9. PubMed ID: 2252313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.